The 3 human RAS genes (HRAS, KRAS, and NRAS) are among the most prevalent drivers of human cancer, with KRAS being mutated in 20-25% of all human tumors and up to 90% in certain cancer types, e.g. pancreatic cancer [2]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.